GTx, Inc. (GTXI) Provides Corporate Update and Reports First Quarter 2013 Financial Results
5/3/2013 7:51:43 AM
More...
|
GTx, Inc. (GTXI) Initiating Phase 2, Open-Label Study of Enobosarm to Treat ER Positive Metastatic Breast Cancer
4/30/2013 12:20:34 PM
More...
|
GTx, Inc. (GTXI) to Host First Quarter 2013 Financial Results Conference Call and Webcast
4/19/2013 7:55:35 AM
More...
|
GTx, Inc. (GTXI)-758 Poster Presentation of Phase II Trial Data in Advanced Prostate Cancer Selected as One of the Best Posters at the 28th Annual European Association of Urology Congress
3/19/2013 9:41:32 AM
More...
|
GTx, Inc. (GTXI) Release: Enobosarm Phase 2 Trial for Muscle Wasting and Physical Function in Patients With Cancer Published in The Lancet Oncology
3/14/2013 9:55:07 AM
More...
|
GTx, Inc. (GTXI) Announces Webcast of Corporate Presentation at Cowen and Company 33rd Annual Health Care Conference
2/27/2013 6:28:17 AM
More...
|
GTx, Inc. (GTXI) Provides Corporate Update and Reports 2012 Financial Results
2/21/2013 6:15:16 AM
More...
|
GTx, Inc. (GTXI) Announces Webcast of Corporate Presentation at 2013 Citi Global Healthcare Conference
2/19/2013 6:17:41 AM
More...
|
GTx, Inc. (GTXI) to Present Preclinical Data on a New Therapeutic Target in Prostate Cancer
2/14/2013 9:53:36 AM
More...
|
GTx, Inc. (GTXI) to Host Fourth Quarter and Full Year 2012 Financial Results Conference Call and Webcast
2/7/2013 6:27:31 AM
More...
|
|